CLINICAL_TRIALS ClinicalTrials.gov record update

Effect of AMD3100 (240µg/kg) on the Apheresis Yield of CD34+ Cells When Given To Multiple Myeloma or Non-Hodgkin's Lymphoma Patients Predicted to be Unable to Mobilize ≥2 x 10^6 CD34+ Cells in Three Apheresis Days When Given G-CSF Alone

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00395967
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:56.073037+00:00
Published At: 2010-08-13T00:00:00+00:00
Record Updated At: 2015-05-01
Results Posted At: 2010-08-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multiple Myeloma", "Lymphoma, Non-Hodgkin\u0027s"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-05-01"
protocolSection.identificationModule.nctId: "NCT00395967"
protocolSection.identificationModule.officialTitle: "Effect of AMD3100 (240\u00b5g/kg) on the Apheresis Yield of CD34+ Cells When Given To Multiple Myeloma or Non-Hodgkin\u0027s Lymphoma Patients Predicted to be Unable to Mobilize \u22652 x 10^6 CD34+ Cells in Three Apheresis Days When Given G-CSF Alone"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-08-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.